ニュース
高シグナルの見出しのみ — マクロイベント、決算、M&A、規制。リスト記事とアナリストのクリックベイトはデフォルトでフィルタ。1時間ごとに更新。
313last 24h
1487last 7d
249🟢 bullish (7d)
152🔴 bearish (7d)
143publishers
Zacks2d agobearish
Regeneron's Late-Stage Melanoma Study Misses Primary GoalREGN's melanoma combo misses the primary endpoint in a phase III study despite longer median PFS versus Keytruda monotherapy.
The Wall Street Journal2d agobearish
Regeneron Stock Tumbles on Melanoma Drug-Trial MissShares of Regeneron Pharmaceuticals are down about 11%, dragging the Nasdaq composite, after the company’s experimental melanoma drug failed a pivotal clinical trial. The company said that its drug fianlimab, when combined with an approved cancer drug, didn't keep patients’ disease from worsening significantly longer than Merck’s Keytruda.
Investor's Business Daily2d agobearish
The Surprising Reason Regeneron Pharmaceuticals Just Dropped 12%Regeneron Pharmaceuticals stock crashed Monday after its experimental melanoma treatment failed in Phase 3 testing.
The Wall Street Journal2d agobearish
Regeneron Melanoma Drug Trial Disappoints and Shares SlideShares tumbled after the drugmaker said a late-stage clinical trial of a skin cancer medication fell short of its target.
24/7 Wall St.14d agobearish
6 Pharma Dividend Stocks Yielding Up to 6.44% — and They’ve Survived Every Market CrashDividend income arrives whether markets rally or sell off. For investors seeking recurring cash flow, high-yield equities remain the cleanest source outside a paycheck. They settle in cash, clear immediately, and can be redeployed or spent without selling property or waiting on private placements. Pharma is one of the few sectors where mature franchises, regulatory ... 6 Pharma Dividend Stocks Yielding Up to 6.44% — and They’ve Survived Every Market Crash